Contraceptive Drugs Market (By Product: Oral, Pills, Intrauterine Devices (IUD), Condoms, Vaginal Ring, Subdermal Implants, Injectable, Others: By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel & NGOs, Others: By Age Group: 15–24 years, 25–34 years, 35–44 years, Above 44 years)- Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024 – 2033
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Contraceptive Drugs Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Contraceptive Drugs Market, by Product, 2024-2033
8.1.1 Oral
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Lead Acid
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Intrauterine Devices (IUD)
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Condoms
8.1.4.1. Market Revenue and Forecast (2021-2033)
8.1.5. Vaginal Ring
8.1.5.1. Market Revenue and Forecast (2021-2033)
8.1.6. Subdermal Implants
8.1.6.1. Market Revenue and Forecast (2021-2033)
8.1.7. Injectable
8.1.7.1. Market Revenue and Forecast (2021-2033)
8.1.8. Others
8.1.8.1. Market Revenue and Forecast (2021-2033)
9.1. Contraceptive Drugs Market, by Distribution Channel, 2024-2033
9.1.1. Hospital Pharmacy
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Retail Pharmacy
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Clinics
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Online Channel
9.1.4.1. Market Revenue and Forecast (2021-2033)
9.1.5. Public Channel & NGOs
9.1.5.1. Market Revenue and Forecast (2021-2033)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2021-2033)
10.1. Contraceptive Drugs Market, by Age Group, 2024-2033
10.1.1. 15–24 years
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. 25–34 years
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. 35–44 years
10.1.3.1. Market Revenue and Forecast (2021-2033)
10.1.4. Above 44 years
10.1.4.1. Market Revenue and Forecast (2021-2033)
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2021-2033)
11.1.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)
11.1.3. Market Revenue and Forecast, by Age Group (2021-2033)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2021-2033)
11.1.4.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)
11.1.4.3. Market Revenue and Forecast, by Age Group (2021-2033)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2021-2033)
11.1.5.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)
11.1.5.3. Market Revenue and Forecast, by Age Group (2021-2033)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2021-2033)
11.2.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)
11.2.3. Market Revenue and Forecast, by Age Group (2021-2033)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2021-2033)
11.2.4.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)
11.2.4.3. Market Revenue and Forecast, by Age Group (2021-2033)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2021-2033)
11.2.5.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)
11.2.5.3. Market Revenue and Forecast, by Age Group (2021-2033)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2021-2033)
11.2.6.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)
11.2.6.3. Market Revenue and Forecast, by Age Group (2021-2033)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2021-2033)
11.2.7.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)
11.2.7.3. Market Revenue and Forecast, by Age Group (2021-2033)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2021-2033)
11.3.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)
11.3.3. Market Revenue and Forecast, by Age Group (2021-2033)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2021-2033)
11.3.4.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)
11.3.4.3. Market Revenue and Forecast, by Age Group (2021-2033)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2021-2033)
11.3.5.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)
11.3.5.3. Market Revenue and Forecast, by Age Group (2021-2033)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2021-2033)
11.3.6.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)
11.3.6.3. Market Revenue and Forecast, by Age Group (2021-2033)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2021-2033)
11.3.7.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)
11.3.7.3. Market Revenue and Forecast, by Age Group (2021-2033)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2021-2033)
11.4.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)
11.4.3. Market Revenue and Forecast, by Age Group (2021-2033)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2021-2033)
11.4.4.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)
11.4.4.3. Market Revenue and Forecast, by Age Group (2021-2033)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2021-2033)
11.4.5.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)
11.4.5.3. Market Revenue and Forecast, by Age Group (2021-2033)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2021-2033)
11.4.6.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)
11.4.6.3. Market Revenue and Forecast, by Age Group (2021-2033)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2021-2033)
11.4.7.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)
11.4.7.3. Market Revenue and Forecast, by Age Group (2021-2033)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2021-2033)
11.5.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)
11.5.3. Market Revenue and Forecast, by Age Group (2021-2033)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2021-2033)
11.5.4.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)
11.5.4.3. Market Revenue and Forecast, by Age Group (2021-2033)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2021-2033)
11.5.5.2. Market Revenue and Forecast, by Distribution Channel (2021-2033)
11.5.5.3. Market Revenue and Forecast, by Age Group (2021-2033)
12.1. Church & Dwight Co., Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Reckitt Benckiser Group Plc
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Veru, Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Organon Group of Companies
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Pfizer, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Teva Pharmaceutical Industries Ltd.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. The Cooper Companies, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Mayer Laboratories, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Agile Therapeutics
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. TherapeuticsmMD, Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample